Related Experiment Video
Updated: Sep 5, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive
Fusheng Zhang1, Haiyang Liu1, Meiqi Duan1
1Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, China.
Abstract:
The tumor microenvironment (TME), which is regulated by intrinsic oncogenic mechanisms and epigenetic modifications, has become a research hotspot in recent years. Characteristic features of TME include hypoxia, metabolic dysregulation, and immunosuppression. One of the most common RNA modifications, N6-methyladenosine (m6A) methylation, is widely involved in the regulation of physiological and pathological processes, including tumor development. Compelling evidence indicates that m6A methylation regulates transcription and protein expression through shearing, export, translation, and processing, thereby participating in the dynamic evolution of TME. Specifically, m6A methylation-mediated adaptation to hypoxia, metabolic dysregulation, and phenotypic shift of immune cells synergistically promote the formation of an immunosuppressive TME that supports tumor proliferation and metastasis. In this review, we have focused on the involvement of m6A methylation in the dynamic evolution of tumor-adaptive TME and described the detailed mechanisms linking m6A methylation to change in tumor cell biological functions. In view of the collective data, we advocate treating TME as a complete ecosystem in which components crosstalk with each other to synergistically achieve tumor adaptive changes. Finally, we describe the potential utility of m6A methylation-targeted therapies and tumor immunotherapy in clinical applications and the challenges faced, with the aim of advancing m6A methylation research.
Insights
N6-methyladenosine (m6A) methylation drives tumor progression by altering the tumor microenvironment (TME). This RNA modification promotes hypoxia, metabolic issues, and immune suppression, supporting cancer growth and spread.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- The tumor microenvironment (TME) is crucial in cancer development, characterized by hypoxia, metabolic dysregulation, and immunosuppression.
- Epigenetic modifications, particularly RNA modifications like N6-methyladenosine (m6A) methylation, play a significant role in TME regulation and tumor progression.
Purpose of the Study:
- To review the involvement of m6A methylation in the dynamic evolution of the tumor-adaptive TME.
- To elucidate the mechanisms linking m6A methylation to changes in tumor cell biological functions and TME characteristics.
Main Methods:
- Literature review focusing on m6A methylation's role in TME.
- Analysis of molecular mechanisms by which m6A influences transcription, protein expression, and cellular processes within the TME.
Main Results:
- m6A methylation regulates key TME features including hypoxia, metabolic dysregulation, and immune cell phenotypes.
- These m6A-mediated adaptations create an immunosuppressive TME that fosters tumor proliferation and metastasis.
- m6A impacts RNA processing, translation, and protein expression, contributing to tumor-adaptive changes.
Conclusions:
- m6A methylation is a key driver of TME evolution towards a tumor-supportive state.
- Targeting m6A methylation presents a promising therapeutic strategy for cancer treatment, potentially enhancing immunotherapy efficacy.
- Viewing the TME as an ecosystem highlights the interconnectedness of its components and the potential for novel therapeutic interventions.
Related Concept Videos
The Tumor Microenvironment
MicroRNAs
Epigenetic Regulation
X-chromosome...
Master Transcription Regulators

